Mockenhaupt, M. et al. 2005. Daclizumab: a novel therapeutic option in severe bullous pemphigoid. Acta Dermato-Venereologica. 85, 1 (Jan. 2005), 65–66. DOI:https://doi.org/10.1080/00015550410022221.